Description
[ CAS No. ] 1226781-44-7
[ Molecular Formula ] C17H20F2N4O3S
[ Molecular Weight ] 398.43
[ Appearance ] White crystalline powder
About Omarigliptin
Omarigliptin is a potent, long-acting oral antidiabetic drug of the DPP-4 inhibitor class used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co. It inhibits DPP-4 to increase incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying and decreases blood glucose levels.
